AV
EW icon

ASR Vermogensbeheer’s Edwards Lifesciences EW Stock Holding History

ASR Vermogensbeheer’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09M Sell
45,234
-38,432
-46% -$3.22M 0.04% 302
2026
Q1 		$6.7M Buy
83,666
+1,827
+2% +$151K 0.08% 216
2025
Q4 		$6.98M Sell
81,839
-765
-0.9% -$62.8K 0.08% 207
2025
Q3 		$6.42M Sell
82,604
-449
-0.5% -$35.1K 0.08% 224
2025
Q2 		$6.5M Sell
83,053
-337
-0.4% -$25.1K 0.08% 216
2025
Q1 		$6.04M Buy
+83,390
New +$5.97M 0.09% 202

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ASR Vermogensbeheer's EW Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Edwards Lifesciences (EW) stake by 46% in Q2 2026, selling an estimated $3.22M and leaving 45,234 shares worth $4.09M. The position accounts for 0.04% of the portfolio, ranked #302.

ASR Vermogensbeheer first reported a position in EW in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.98M in Q4 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • ASR Vermogensbeheer held 45,234 shares of Edwards Lifesciences worth $4.09M as of Q2 2026.
  • ASR Vermogensbeheer sold 38,432 Edwards Lifesciences shares in Q2 2026, an estimated $3.22M.
  • Edwards Lifesciences made up 0.04% of ASR Vermogensbeheer's portfolio in Q2 2026, its #302 holding.
  • ASR Vermogensbeheer first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Edwards Lifesciences position peaked at $6.98M in Q4 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.